These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9351068)

  • 1. Ambulatory blood pressure in hypertensive patients with autosomal dominant polycystic kidney disease.
    Li Kam Wa TC; Macnicol AM; Watson ML
    Nephrol Dial Transplant; 1997 Oct; 12(10):2075-80. PubMed ID: 9351068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left ventricular hypertrophy in hypertensive patients with autosomal dominant polycystic kidney disease: influence of blood pressure and humoral and neurohormonal factors.
    Martinez-Vea A; Valero FA; Bardaji A; Gutierrez C; Broch M; Garcia C; Richart C; Oliver JA
    Am J Nephrol; 2000; 20(3):193-200. PubMed ID: 10878400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sympathetic activity and blood pressure pattern in autosomal dominant polycystic kidney disease hypertensives.
    Cerasola G; Vecchi M; Mulè G; Cottone S; Mangano MT; Andronico G; Contorno A; Parrino I; Renda F; Pavone G
    Am J Nephrol; 1998; 18(5):391-8. PubMed ID: 9730562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ambulatory blood pressure correlates with renal volume and number of renal cysts in children with autosomal dominant polycystic kidney disease.
    Seeman T; Dusek J; Vondrichová H; Kyncl M; John U; Misselwitz J; Janda J
    Blood Press Monit; 2003 Jun; 8(3):107-10. PubMed ID: 12900587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relationship between renal size and blood pressure profile in patients with autosomal dominant polycystic kidney disease without renal failure].
    Sans Atxer L; Roca-Cusachs A; Torra R; Calero F; Arias P; Ballarin J; Fernández-Llama P
    Nefrologia; 2010; 30(5):567-72. PubMed ID: 20882096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal volume and cardiovascular risk assessment in normotensive autosomal dominant polycystic kidney disease patients.
    Sans L; Pascual J; Radosevic A; Quintian C; Ble M; Molina L; Mojal S; Ballarin JA; Torra R; Fernández-Llama P
    Medicine (Baltimore); 2016 Dec; 95(49):e5595. PubMed ID: 27930582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The reproducibility of the circadian BP rhythm in treated hypertensive patients with polycystic kidney disease and mild chronic renal impairment--a prospective ABPM study.
    Covic A; Mititiuc I; Gusbeth-Tatomir P; Goldsmith DJ
    J Nephrol; 2002; 15(5):497-506. PubMed ID: 12455715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular manifestations of autosomal dominant polycystic kidney disease in young adults.
    Handa SP
    Clin Invest Med; 2006 Dec; 29(6):339-46. PubMed ID: 17330449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A link between the intrarenal renin angiotensin system and hypertension in autosomal dominant polycystic kidney disease.
    Kocyigit I; Yilmaz MI; Unal A; Ozturk F; Eroglu E; Yazici C; Orscelik O; Sipahioglu MH; Tokgoz B; Oymak O
    Am J Nephrol; 2013; 38(3):218-25. PubMed ID: 23988725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood pressure and intracranial aneurysms in autosomal dominant polycystic kidney disease.
    Niemczyk M; Pilecki T; Gradzik M; Bujko M; Niemczyk S; Pączek L
    Kidney Blood Press Res; 2014; 39(6):630-5. PubMed ID: 25571876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood pressure and renal function in autosomal dominant polycystic kidney disease.
    Seeman T; Sikut M; Konrad M; Vondrichová H; Janda J; Schärer K
    Pediatr Nephrol; 1997 Oct; 11(5):592-6. PubMed ID: 9323285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ambulatory blood pressure and left ventricular mass in normotensive patients with autosomal dominant polycystic kidney disease.
    Valero FA; Martinez-Vea A; Bardají A; Gutierrez C; Garcia C; Richart C; Oliver JA
    J Am Soc Nephrol; 1999 May; 10(5):1020-6. PubMed ID: 10232688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of Hypertension in Children with Early-Stage ADPKD.
    Massella L; Mekahli D; Paripović D; Prikhodina L; Godefroid N; Niemirska A; Ağbaş A; Kalicka K; Jankauskiene A; Mizerska-Wasiak M; Afonso AC; Salomon R; Deschênes G; Ariceta G; Özçakar ZB; Teixeira A; Duzova A; Harambat J; Seeman T; Hrčková G; Lungu AC; Papizh S; Peco-Antic A; De Rechter S; Giordano U; Kirchner M; Lutz T; Schaefer F; Devuyst O; Wühl E; Emma F
    Clin J Am Soc Nephrol; 2018 Jun; 13(6):874-883. PubMed ID: 29674338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of OSR-1 With Vascular Dysfunction and Hypertension in Polycystic Kidney Disease.
    Kocyigit I; Taheri S; Eroglu E; Zararsiz G; Sener EF; Uzun I; Imamoglu H; Mehmetbeyoglu E; Unal A; Korkmaz K; Sipahioglu MH; Oymak O; Tokgoz B
    Ther Apher Dial; 2020 Feb; 24(1):64-71. PubMed ID: 31020807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertension in children with autosomal dominant polycystic kidney disease (ADPKD).
    Cadnapaphornchai MA
    Curr Hypertens Rev; 2013 Feb; 9(1):21-6. PubMed ID: 23971640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nocturnal blood pressure and relation to vasoactive hormones and renal function in hypertension and chronic renal failure.
    Jensen LW; Pedersen EB
    Blood Press; 1997 Nov; 6(6):332-42. PubMed ID: 9495658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress in blood pressure control in autosomal dominant polycystic kidney disease.
    Ecder T; Edelstein CL; Fick-Brosnahan GM; Johnson AM; Duley IT; Gabow PA; Schrier RW
    Am J Kidney Dis; 2000 Aug; 36(2):266-71. PubMed ID: 10922304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease.
    Zeltner R; Poliak R; Stiasny B; Schmieder RE; Schulze BD
    Nephrol Dial Transplant; 2008 Feb; 23(2):573-9. PubMed ID: 17984104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ambulatory pulse pressure and its contributors in autosomal dominant polycystic kidney disease.
    Koska-Ścigała A; Jankowska M; Szyndler A; Narkiewicz K; Dębska-Ślizień A
    Adv Clin Exp Med; 2022 May; 31(5):575-578. PubMed ID: 35543199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ambulatory blood pressure and endothelial dysfunction in patients with autosomal dominant polycystic kidney disease.
    Turgut F; Oflaz H; Namli S; Alisir S; Tufan F; Temiz S; Umman S; Ecder T
    Ren Fail; 2007; 29(8):979-84. PubMed ID: 18067044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.